Compounds > farnesol

farnesol and Liver Neoplasms

farnesol has been researched along with Liver Neoplasms in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's2 (15.38)29.6817
2010's6 (46.15)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Balaraman, G; Krishnan, P; Mari, A; Salam, S; Sirajduddin, I; Subramaniam, N; Sundaram, J; Thiruvengadam, D1
Khuda-Bukhsh, AR; Mondal, J1
Chen, Y; Cheng, W; Dong, J; Jing, H; Liang, X; Liu, J; Shang, H; Wang, C; Wang, D; Wu, B; Yuan, Y; Zhou, Y1
Chen, T; Pang, Y; Qin, G; Wang, X; Wu, L; Wu, S; Xi, G1
Abarca, J; Borbath, I; Charette, N; De Saeger, C; Horsmans, Y; Leclercq, I; Schneider-Merck, T; Stärkel, P1
Charette, N; De Saeger, C; Horsmans, Y; Lannoy, V; Leclercq, I; Stärkel, P1
Ji, H; Lai, Y; Ling, Y; Peng, S; Tian, J; Ye, X; Zhang, Y; Zhang, Z1
Borbath, I; Stärkel, P1
Ji, H; Ling, Y; Tang, J; Yang, L; Zhang, Y; Zhang, Z; Zhao, Q1
Charette, N; De Saeger, C; Horsmans, Y; Leclercq, I; Stärkel, P1
Dagli, ML; de Conti, A; Heidor, R; Moreno, FS; Ong, TP1
Crick, DC; Feller, DR; Henry, KW; Noonan, DJ; O'Brien, ML; Rangwala, SM; Waechter, CJ; Weinberger, C1
Noonan, DJ; O'Brien, ML1

Reviews

1 review(s) available for farnesol and Liver Neoplasms

ArticleYear
A hypothetical mechanism for fat-induced rodent hepatocarcinogenesis.
    Advances in experimental medicine and biology, 1997, Volume: 422

    Topics: Animals; DNA-Binding Proteins; Farnesol; Fats; Humans; Liver Neoplasms; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Rodentia; Transcription Factors

1997

Other Studies

12 other study(ies) available for farnesol and Liver Neoplasms

ArticleYear
Farnesol alleviates diethyl nitrosamine induced inflammation and protects experimental rat hepatocellular carcinoma.
    Environmental toxicology, 2021, Volume: 36, Issue:12

    Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Diethylnitrosamine; Farnesol; Inflammation; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Oxidative Stress; Rats; Rats, Wistar

2021
Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitro.
    Molecular biology reports, 2020, Volume: 47, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Delivery Systems; Drug Synergism; Farnesol; Humans; Liver Neoplasms; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species

2020
Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma.
    Journal of nanobiotechnology, 2021, Jun-12, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Diathermy; Disease Models, Animal; Endothelial Cells; Farnesol; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; ras Proteins; Salicylates; Sequence Analysis, RNA

2021
Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.
    PloS one, 2017, Volume: 12, Issue:2

    Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Artemisinins; Carcinoma, Hepatocellular; Drug Synergism; Farnesol; Hep G2 Cells; Humans; Liver Neoplasms; Salicylates

2017
The Ras inhibitor farnesylthiosalicyclic acid (FTS) prevents nodule formation and development of preneoplastic foci of altered hepatocytes in rats.
    European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Diethylnitrosamine; Farnesol; Gene Expression Regulation, Neoplastic; Genes, ras; Hepatocytes; Immunohistochemistry; Liver Neoplasms; Male; Models, Animal; Rats; Rats, Wistar; Salicylates

2009
Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
    Molecular cancer, 2010, Sep-22, Volume: 9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Farnesol; Female; Hep G2 Cells; Humans; Inhibitor of Apoptosis Proteins; Insulin-Like Growth Factor II; Liver Neoplasms; Mice; Mice, Nude; Microtubule-Associated Proteins; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; Salicylates; Survivin; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2010
Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Journal of medicinal chemistry, 2011, May-12, Volume: 54, Issue:9

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Farnesol; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitric Oxide Donors; Oxadiazoles; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Salicylates; Stereoisomerism; Structure-Activity Relationship; Toxicity Tests, Acute; Transplantation, Heterologous

2011
Chemoprevention of hepatocellular carcinoma. Proof of concept in animal models.
    Acta gastro-enterologica Belgica, 2011, Volume: 74, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Farnesol; Humans; Hypoglycemic Agents; Liver Neoplasms; Peptides, Cyclic; Pioglitazone; Salicylates; Somatostatin; Thiazolidinediones

2011
ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways.
    Biochemical and biophysical research communications, 2011, Jun-17, Volume: 409, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Enzyme Activation; Farnesol; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred ICR; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide; Oxadiazoles; Salicylates

2011
Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms.
    Cell death & disease, 2013, Jan-24, Volume: 4

    Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Caspase 8; Caspase 9; Cell Line, Tumor; Farnesol; Hep G2 Cells; Hepatocytes; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Mitochondria; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Proteins; Salicylates; Survivin; TNF-Related Apoptosis-Inducing Ligand

2013
Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase.
    Carcinogenesis, 2006, Volume: 27, Issue:6

    Topics: Acyclic Monoterpenes; Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cholesterol; Comet Assay; DNA Damage; Farnesol; Hepatocytes; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms; Male; Rats; Rats, Wistar; Terpenes

2006
Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis.
    Carcinogenesis, 1996, Volume: 17, Issue:2

    Topics: Acyl-CoA Oxidase; Animals; Anticholesteremic Agents; Cholesterol; Farnesol; Fatty Acids, Unsaturated; Liver Neoplasms; Lovastatin; Microbodies; Oxidoreductases; Polyisoprenyl Phosphates; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Sesquiterpenes; Transcription Factors

1996